FDA increases import of Chinese cancer drugs due to shortage
The Food and Drug Administration (FDA) is taking steps to alleviate the shortage of key chemotherapy treatments in the U.S. by allowing more cancer drugs from China. Specifically, the FDA has granted permission for 10 additional lots of the commonly used cancer drug cisplatin to be distributed by Qilu Pharmaceutical, a Chinese company. Cisplatin, along …
